Syndax Pharmaceuticals Inc — Form D

Syndax Pharmaceuticals Inc of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-14. The offering totals $50K, of which $50K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Ivor RoystonDirectorLa Jolla, CA
Arlene MorrisDirectorHolytown, Motherwell, X0
Arlene MorrisExecutive OfficerHolytown, Motherwell, X0
Dennis PodlesakDirectorSAN DIEGO, CA
Kim Kamdar, Ph.D.DirectorSan Diego, CA
Fabrice Egros, Ph.D.DirectorWaltham, MA
Michael W MetzgerExecutive OfficerWaltham, MA
Kim Kamdar, Ph.DDirectorWaltham, MA
Luke Evnin, Ph.D.DirectorWaltham, MA
Ivor Royston, M.D.DirectorWaltham, MA
George W Sledge, Jr., M.D.DirectorWaltham, MA
John PalliesExecutive OfficerWaltham, MA
Richard P SheaDirectorWaltham, MA
Henry W ChenDirectorWaltham, MA
Briggs W Morrison, M.D.DirectorWaltham, MA
Briggs W Morrison, M.D.Executive OfficerWaltham, MA
George W Sledge, Jr. M.D.DirectorWaltham, MA
Fabrice EgrosDirectorWaltham, MA
Steven St. Peter, M.D.DirectorWaltham, MA
Joanna Horobin, M.D.DirectorWaltham, MA
Joanna Horobin, M.D.Executive OfficerWaltham, MA
Kim Kamdar, PhDDirectorWaltham, MA
Rosina Maar Pavia, M.D.DirectorWaltham, MA
Robert Goodenow, PhDExecutive OfficerWaltham, MA
Robert Goodenow, Ph.D.Executive OfficerWaltham, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2015-08-28D$61.3M$61.3M
2015-06-15D$45.2M$24.0M
2014-09-19D$5.0M$4.9M
2014-02-13D$1.3M$1.3M
2014-02-13D$1.7M$1.7M
2013-08-30D$48.4M$31.3M
2010-08-05D$7.0M$6.0M
2010-02-03D$16.0M$9.0M

More